{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:03:01Z","timestamp":1792605781349,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2025,4,15]]},"abstract":"<jats:p xml:lang=\"en\">Nonspecific symptoms and other diagnostic challenges lead to underdiagnosis of cardiac amyloidosis (CA). Artificial intelligence (AI) could help address these challenges, but a summary of the performance of these tools is lacking. This narrative review of published literature describes the performance of AI tools that use data from ECGs and echocardiography to improve identification of CA and challenges that hinder adoption of these tools. Thirteen studies met inclusion criteria with sample sizes ranging from 50 to 2451 patients. Four studies used ECG data, 8 used echocardiography data, and 1 used both. The CA gold standard was typically defined as a CA diagnosis in an institutional or other database but the requirements for these diagnoses were heterogenous across studies, and many did not distinguish among CA subtypes. AI model development varied considerably, and only 4 studies included external validation. The ability of models to predict CA ranged from 0.71 to 1.00, sensitivity ranged from 16% to 100%, and specificity from 75% to 100%. Only 1 study reported model performance across strata of sex, age, race, and CA type. Persistent challenges to AI adoption include usability, cost, value added, electronic health record\/information technology interoperability, patient\u2010related factors, regulation, and privacy and liability. Published studies on AI for improved identification of CA show favorable performance measures but numerous methodologic and other challenges must be addressed before these tools are more widely adopted.<\/jats:p>","DOI":"10.1161\/jaha.124.036533","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:53:06Z","timestamp":1744264386000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review"],"prefix":"10.1161","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2541-4440","authenticated-orcid":false,"given":"Martha","family":"Grogan","sequence":"first","affiliation":[{"name":"Mayo Clinic","place":["Rochester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5788-9734","authenticated-orcid":false,"given":"Francisco","family":"Lopez\u2010Jimenez","sequence":"additional","affiliation":[{"name":"Mayo Clinic","place":["Rochester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-4586","authenticated-orcid":false,"given":"Spencer","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Attralus","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisith","family":"Kumar","sequence":"additional","affiliation":[{"name":"Pfizer Inc.","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Langevin","sequence":"additional","affiliation":[{"name":"Amyloidosis Research Consortium","place":["Newton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3506-0359","authenticated-orcid":false,"given":"Isabelle","family":"Lousada","sequence":"additional","affiliation":[{"name":"Amyloidosis Research Consortium","place":["Newton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-1472","authenticated-orcid":false,"given":"Ronald","family":"Witteles","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine","place":["Stanford, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4440-4755","authenticated-orcid":false,"given":"Ajay","family":"Royyuru","sequence":"additional","affiliation":[{"name":"IBM Research","place":["Yorktown Heights, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5158-5131","authenticated-orcid":false,"given":"Michael","family":"Rosenzweig","sequence":"additional","affiliation":[{"name":"City of Hope National Cancer Center","place":["Duarte, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5376-3402","authenticated-orcid":false,"given":"Sarah","family":"Cairns\u2010Smith","sequence":"additional","affiliation":[{"name":"Amyloidosis Research Consortium","place":["Newton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-7518","authenticated-orcid":false,"given":"David","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Cedars\u2010Sinai Medical Center","place":["Los Angeles, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13169"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2018.1549825"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2022.08.009"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.14797\/mdcvj.1066"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2021.2013193"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062273"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.11.004"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016402"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100519"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2551964"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-021-00219-5"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13679"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.2093"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054655"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02584-3"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13913"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-019-01490-2"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02425-3"},{"key":"e_1_3_2_20_2","unstructured":"Amyloidosis stakeholder partnerships for impact reach and equity. 2023. Accessed March 12 2024. https:\/\/arci.org\/aspire\/."},{"key":"e_1_3_2_21_2","unstructured":"Amyloidosis Research Consortium . 2023. Accessed March 12 2024. https:\/\/arci.org\/"},{"key":"e_1_3_2_22_2","unstructured":"Amyloidosis Research Consortium . ASPIRE: amyloidosis stakeholder partnerships for impact reach and equity. Accessed September 20 2023. https:\/\/arci.org\/aspire\/."},{"key":"e_1_3_2_23_2","unstructured":"Amyloidosis Research Consortium . ARC & ASPIRE: partnerships for patient\u2010centric change. Accessed September 20 2023. https:\/\/arci.org\/arc\u2010aspire\u2010partnerships\u2010for\u2010patient\u2010centric\u2010change\/."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/echo.15516"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.6059"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22877-8"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.04.023"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvdhj.2023.03.001"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100612"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25467-w"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/jimaging9020048"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-319846"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-022-02738-1"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-021-02461-3"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034338"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-023-02806-0"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072734"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051334"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvdhj.2023.04.003"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133910"},{"key":"e_1_3_2_41_2","volume-title":"Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet\u2010Screening)","year":"2023","unstructured":"Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet\u2010Screening). ClinicalTrials.gov Identifier: NCT05139797. National Institutes of Health; 2023. Accessed March 12, 2024. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05139797?term=echonet&draw=2&rank=1"},{"key":"e_1_3_2_42_2","unstructured":"Artificial intelligence enhanced ECG to detect cardiac amyloidosis. Accessed March 12 2024. https:\/\/www.mayo.edu\/research\/clinical\u2010trials\/cls\u201020551011."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01312-x"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065680"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.058696"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2140"},{"key":"e_1_3_2_47_2","unstructured":"Food and Drug Administration . Breakthrough Devices Program. Accessed September 20 2023. https:\/\/www.fda.gov\/medical\u2010devices\/how\u2010study\u2010and\u2010market\u2010your\u2010device\/breakthrough\u2010devices\u2010program."},{"key":"e_1_3_2_48_2","unstructured":"Cardiac Interventions . Viz.ai's hypertrophic cardiomyopathy ai algorithm approved by FDA. Accessed September 20 2023. https:\/\/citoday.com\/news\/vizais\u2010hypertrophic\u2010cardiomyopathy\u2010ai\u2010algorithm\u2010approved\u2010by\u2010fda."},{"key":"e_1_3_2_49_2","article-title":"FDA has now cleared more than 500 healthcare AI algorithms","volume":"6","author":"Fornell D","year":"2023","unstructured":"Fornell D. FDA has now cleared more than 500 healthcare AI algorithms. Healthc Exec. 2023;6. Accessed September 20, 2023. https:\/\/healthexec.com\/topics\/artificial\u2010intelligence\/fda\u2010has\u2010now\u2010cleared\u2010more\u2010500\u2010healthcare\u2010ai\u2010algorithms","journal-title":"Healthc Exec"},{"key":"e_1_3_2_50_2","unstructured":"Food and Drug Administration . Artificial intelligence and machine learning in software as a medical device. Accessed September 20 2023. https:\/\/www.fda.gov\/medical\u2010devices\/software\u2010medical\u2010device\u2010samd\/artificial\u2010intelligence\u2010and\u2010machine\u2010learning\u2010software\u2010medical\u2010device."},{"key":"e_1_3_2_51_2","unstructured":"Food and Drug Administration . Artificial intelligence\/machine learning (AI\/ML)\u2010based Software as a Medical Device (SaMD) action plan. Accessed September 20 2023. https:\/\/www.fda.gov\/media\/145022\/download."}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.124.036533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:53:59Z","timestamp":1783943639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.124.036533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,4,15]]}},"alternative-id":["10.1161\/JAHA.124.036533"],"URL":"https:\/\/doi.org\/10.1161\/jaha.124.036533","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"2025-04-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e036533"}}